Presentation TCT 2017 TCT 13: A First-in-Man Study of the Firesorb Sirolimus Target Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease (FUTURE-I) - One-Year Clinical and Imaging Outcomes Presenter: Stephan Achenbach, Jacques J. Koolen, Bo Xu October 31, 2017